Towards achieving the 90–90–90 HIV targets: results from the south African 2017 national HIV survey
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
Background: Measuring progress towards the Joint United Nations Programme on HIV/AIDS (UNAIDS) 90–90–90 treatment targets is key to assessing progress towards turning the HIV epidemic tide. In 2017, the UNAIDS model estimated that 75% of people living with HIV (PLHIV) globally knew their HIV positive status, 79% of those who knew their status were on antiretroviral therapy (ART), and 81% of those who knew their HIV status and were on ART had a suppressed viral load. The fifth South African national HIV sero-behavioural survey collected nationally representative data that enabled the empirical estimation of these 90–90–90 targets for the country stratified by a variety of key factors. Methods: To evaluate progress towards achievement of the 90–90–90 targets for South Africa, data obtained from a national, representative, cross-sectional population-based multi-stage stratified cluster random survey conducted in 2017 were analysed. The Fifth South African National HIV Prevalence, Incidence, Behaviour and Communication Survey (SABSSM V), collected behavioural and biomarker data from individuals residing in households from 1000 randomly selected Small Area Layers (SALs), across all nine provinces of the country. Structured questionnaires were used to collect socio-demographic data, knowledge and perceptions about HIV, and related risk behaviours. Blood samples were collected to test for HIV infection, antiretroviral use, and viral suppression (defined as < 1000 copies/ml). Weighted proportions of study participants aged 15 years and older who tested HIV positive were computed for those who reported awareness of their status (1st 90), and among these, those who were currently on ART (2nd 90) and of these, those who were virally suppressed (3rd 90). Results: Among persons 15 years and older who were HIV positive, 84.8% were aware of their HIV positive status, of whom 70.7% were currently on ART, with 87.4% of these estimated to have suppressed viral load at the time of the survey. These estimates varied by sex, age, and geo-location type. Relatively higher percentages across all three indicators for women compared to men were observed: 88.7% versus 78.2% for those aware of their status, 72.3% versus 67.7% for on ART, and 89.8% versus 82.3% for viral suppression. Knowing one’s positive HIV status increased with age: 74.0, 85.8, and 88.1% for age groups 15–24 years old, 25–49 years old and 50–64 years old, although for those 65 years and older, 78.7% knew their HIV positive status. A similar pattern was observed for the 2nd 90, among those who knew their HIV positive status, 51.7% of 15 to 24 year olds, 70.5% of those aged 25–49 years old, 82.9% of those aged 50–64 years old and 82.4% of those aged 65 years or older were currently on ART. Viral suppression for the above mentioned aged groups, among those who were on ART was 85.2, 87.2, 89.5, and 84.6% respectively. The 90–90–90 indicators for urban areas were 87.7, 66.5, and 87.2%, for rural settings was 85.8, 79.8, and 88.4%, while in commercial farming communities it was 56.2, 67.6 and 81.4%. Conclusions: South Africa appears to be on track to achieve the first 90 indicator by 2020. However, it is behind on the second 90 indicator with ART coverage that was ~ 20-percentage points below the target among people who knew their HIV status, this indicates deficiencies around linkage to and retention on ART. Overall viral suppression among those on ART is approaching the target at 87.4%, but this must be interpreted in the context of low reported ART coverage as well as with variation by age and sex. Targeted diagnosis, awareness, and treatment programs for men, young people aged 15–24 years old, people who reside in farming communities, and in specific provinces are needed. More nuanced 90–90–90 estimates within provinces, specifically looking at more granular sub-national level (e.g. districts), are needed to identify gaps in specific regions and to inform provincial interventions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“only about 69% of South African adult women living with HIV (WLWH) are virally suppressed [1].”
From Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa (2021) · cites this paper as [1]
Experimental — accuracy not yet measuredIn the citing paper
“South African women continue to be disproportionately affected by HIV—comprising about 60% of the estimated 7.9 million South Africans living with HIV [1].”
From Associations Between Patterns of Alcohol Use and Viral Load Suppression Amongst Women Living with HIV in South Africa (2021) · cites this paper as [1]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
South African National HIV Prevalence, Incidence and Behaviour Survey, 2012
Shisana, O., Rehle, T. M., Simbayi, L. C., Zuma, K. K., Jooste, S. E., Zungu, N. P., Labadarios, D., & Onoya, D. (2014) · Cited by 1,645
Self-citationRodger, A. J., Cambiano, V., Bruun, T., Vernazza, P., Collins, S., van Lunzen, J., Corbelli, G. M., Estrada, V., Geretti, A. M., Beloukas, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.5148 · Cited by 1,431
Samji, H., Cescon, A., Hogg, R. S., Modur, S. P., Althoff, K. N., Buchacz, K., Burchell, A. N., Cohen, M., Gebo, K. A., Gill, M. J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081355 · Cited by 1,417
Tanser, F., Bärnighausen, T., Grapsa, E., Zaidi, J., & Newell, M.-L. (2013) · Science · doi:10.1126/science.1228160 · Cited by 796
Grinsztejn, B., Hosseinipour, M. C., Ribaudo, H. J., Swindells, S., Eron, J., Chen, Y. Q., Wang, L., Ou, S.-S., Anderson, M., McCauley, M., et al. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70692-3 · Cited by 494
Govindasamy, D., Meghij, J., Negussi, E. K., Baggaley, R. C., Ford, N., & Kranzer, K. (2014) · Journal of the International AIDS Society · doi:10.7448/ias.17.1.19032 · Cited by 277
Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa
Johnson, L. F., Dorrington, R. E., & Moolla, H. (2017) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v18i1.694 · Cited by 189
Bazzoli, C., Jullien, V., Le Tiec, C., Rey, E., Mentré, F., & Taburet, A.-M. (2010) · Clinical Pharmacokinetics · doi:10.2165/11318110-000000000-00000 · Cited by 165 · cited 1×
“most ART drugs [1], would have tested ARV negative.”
BackgroundHIV testing and linkage to services for youth
Kurth, A., Lally, M., Choko, A. T., Inwani, I. W., & Fortenberry, J. D. (2015) · Journal of the International AIDS Society · doi:10.7448/ias.18.2.19433 · Cited by 134
Simbayi, L. C., Zuma, K. K., Zungu, N. P., Moyo, S., Marinda, E. T., Jooste, S., Mabaso, M., Ramlagan, S., North, A., van Zyl, J., et al. (2019) · Cited by 132
Self-citation
Research works printed but not linked: 6
- NDoH, S. A NDoH and WHO guidelines 2016
- NDoH, S. A Annual Report 2018
- PHIA A drop that counts 2019
- UNAIDS 90–90-90 an ambitious treatment target to end the AIDS epidemic 2014
- UNAIDS Ending AIDS Progress towards the 90–90-90 targets 2017
- WHO Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV 2015 26598776
Cited by
Achieving the 95 95 95 targets for all: A pathway to ending AIDS
Frescura, L., Godfrey-Faussett, P., Feizzadeh, A., El-Sadr, W., Syarif, O., Ghys, P. D., & on behalf of the 2025 testing treatment target Working Group (2022) · PLOS ONE · doi:10.1371/journal.pone.0272405 · Cited by 442
Bekker, L.-G., Beyrer, C., Mgodi, N., Lewin, S. R., Delany-Moretlwe, S., Taiwo, B., Masters, M. C., & Lazarus, J. V. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00452-3 · Cited by 241
Aging with HIV: Increased Risk of HIV Comorbidities in Older Adults
Roomaney, R. A., van Wyk, B. E., & Wyk, V. P. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19042359 · Cited by 101
“It is envisaged that the number of PLWH on ART is likely to continue to grow as the country endeavors to meet ART coverage targets [5].”
BackgroundMen missing from the HIV care continuum in sub‐Saharan Africa: a meta‐analysis and meta‐synthesis
Nardell, M. F., Adeoti, O., Peters, C., Kakuhikire, B., Govathson, C., Long, L. C., Pascoe, S. J. S., Tsai, A. C., & Katz, I. T. (2022) · Journal of the International AIDS Society · doi:10.1002/jia2.25889 · Cited by 75
Eaton, J. W., Dwyer‐Lindgren, L., Gutreuter, S., O’Driscoll, M., Stevens, O., Bajaj, S., Ashton, R., Hill, A., Russell, E., Esra, R. T., et al. (2021) · Journal of the International AIDS Society · doi:10.1002/jia2.25788 · Cited by 57
“Recent household surveys have included biomarker tests for antiretroviral use, which may inform spatial patterns of treatment coverage [17,18].”
Background
Metadata
- Authors
- Marinda, E., Simbayi, L., Zuma, K., Zungu, N., Moyo, S., Kondlo, L., Jooste, S., Nadol, P., Igumbor, E., Dietrich, C., & Briggs-Hagen, M.
- Affiliations
- Human Sciences Research Council (ZA)
- Centers for Disease Control and Prevention (US)
- Corresponding author
- Marinda, Edmore
- ORCID
- Venue
- BMC Public Health
- Published
- 2020-09-09
- Volume
- 20
- Issue
- 1
- Pages
- 1375-1375
- ISSN
- 1471-2458 (ISSN-L)
- PMC
- PMC7487872
- OpenAlex
- W3084024140
- Cited by
- 131
- References
- 26
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 29 · 2023: 26 · 2022: 39 · 2021: 17 · 2020: 1
- FWCI
- 2.72
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- BMC Public Health (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UWC Research Repository (University of the Western Cape) (submittedVersion)
- Funders
- Centers for Disease Control and Prevention (NU2GGH001629)
- Department of Science and Innovation
- South African National AIDS Council
- Global Fund to Fight AIDS, Tuberculosis and Malaria
- UNICEF
- The Centre for Communication Impact, Soul City, and loveLife
- Topics
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › HIV/AIDS Impact and Responses
- Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
- Keywords
- 90-90-90 targets, antiretroviral therapy coverage, viral suppression, HIV status awareness, people living with HIV, South Africa, HIV prevalence
- MeSH terms
- Achievement, Acquired Immunodeficiency Syndrome, Adolescent, Adult, Aged, Aged, 80 and over, Awareness, Cross-Sectional Studies, Female, Goals, Humans, Male, Middle Aged, Surveys and Questionnaires, Rural Population, South Africa, United Nations, HIV Infections, Incidence, Prevalence, Viral Load, Anti-Retroviral Agents, Young Adult, Epidemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Towards achieving the 90–90–90 HIV targets: results from the south African 2017 national HIV survey. https://app.cochat.ai/papers/10.1186/s12889-020-09457-z
- The paper
- Marinda, E., Simbayi, L., Zuma, K., Zungu, N., Moyo, S., Kondlo, L., Jooste, S., Nadol, P., Igumbor, E., Dietrich, C., & Briggs-Hagen, M. (2020). Towards achieving the 90–90–90 HIV targets: results from the south African 2017 national HIV survey. BMC Public Health. https://doi.org/10.1186/s12889-020-09457-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.